Position in CGC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$453,435
+$123,189 QoQ
Shares Held
477,300
+37.2% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 212 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $92,574,463 across 16 Drug Manufacturers - Specialty & Generic names. CGC ranks #13 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,685 | $29,609,949 | |
| 2 | ZTS |
Zoetis Inc.
|
268,075 | $19,263,869 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
2,367,493 | $9,967,145 | |
| 4 | VTRS |
Viatris Inc
|
572,287 | $9,087,917 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
15,849 | $8,587,463 | |
| 6 | CRON |
Cronos Group Inc.
|
1,597,039 | $4,439,768 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
347,299 | $3,472,990 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
91,604 | $3,103,543 |
All Filings in CGC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $453,435 | 477,300 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $330,246 | 347,994 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $348,358 | 305,578 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $163,439 | 111,945 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $102,628 | 84,122 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $45,875 | 50,413 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $88,258 | 32,211 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $160,424 | 33,283 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $213,914 | 33,165 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $252,867 | 29,301 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $117,949 | 23,082 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $135,717 | 173,330 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $51,470 | 132,655 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $228,259 | 130,434 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $296,881 | 128,520 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $301,785 | 110,544 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $281,634 | 98,819 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $897,790 | 118,442 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,176,655 | 134,783 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,588,356 | 114,600 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,666,110 | 110,261 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $3,819,449 | 119,246 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $629,625 | 25,553 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $389,776 | 27,219 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $214,782 | 13,291 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||